Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$978,086
+$79,462 QoQ
Shares Held
2,701
+5.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,713
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. AMGN ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,549 | $1,899,630 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,670 | $985,595 | |
| 3 | AMGN |
Amgen Inc
This page
|
2,701 | $978,086 | |
| 4 | JNJ |
Johnson & Johnson
|
3,548 | $901,085 | |
| 5 | LLY |
ELI LILLY & Co
|
343 | $411,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,249 | $410,478 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,458 | $372,109 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $978,086 | 2,701 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $898,624 | 2,554 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $820,238 | 2,506 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $810,760 | 2,873 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $879,511 | 3,150 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,076,093 | 3,454 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,058,980 | 4,063 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,255,007 | 3,895 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,262,298 | 4,040 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,367,863 | 4,811 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,385,664 | 4,811 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,499,143 | 5,578 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,221,110 | 5,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,103,588 | 4,565 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,192,648 | 4,541 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,023,541 | 4,541 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,104,825 | 4,541 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,098,104 | 4,541 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,021,588 | 4,541 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $966,706 | 4,546 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,100,043 | 4,513 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,122,879 | 4,513 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,037,628 | 4,513 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,148,803 | 4,520 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,155,242 | 4,898 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,010,203 | 4,983 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||